Market Stabilisation Scheme (MSS)

The Market Stabilisation Scheme (MSS) originated in 2004 as a sterilisation instrument designed to address a structural problem in India's monetary management: large and sustained foreign exchange inflows that, when purchased by the Reserve Bank of India to prevent rupee appreciation, injected an equivalent volume of rupee liquidity into the banking system. The scheme was formalised through a Memorandum of Understanding signed between the Government of India and the RBI on 25 March 2004, and operationalised from April 2004. Its statutory underpinning rests in the Government of India's borrowing powers under Article 292 of the Constitution and the issuance machinery of the Government Securities Act, 2006 (earlier the Public Debt Act, 1944). Crucially, the MSS was conceived because the RBI's existing stock of government securities—the ammunition for outright open market sales—was being depleted faster than sterilisation needs demanded, leaving the central bank without adequate instruments to drain durable liquidity.

The procedural mechanics distinguish the MSS from ordinary government borrowing. The Government of India issues Treasury Bills and dated securities specifically designated as MSS securities, but the money raised is not used to finance the fiscal deficit. Instead, the proceeds are sequestered in a separate, identifiable cash account—the MSS Account—maintained with the RBI and held outside the Consolidated Fund of India. The funds in this account cannot be appropriated for government expenditure; they remain frozen, neutralising the liquidity that the underlying securities have absorbed from the market. The interest paid on MSS securities, by contrast, is borne by the government budget and shown as expenditure, representing the carrying cost of sterilisation. An annual ceiling on the outstanding MSS stock is fixed jointly by the government and the RBI, reviewed periodically, and the RBI conducts the auctions following its normal calendar for treasury operations.

Several operational variants exist within the framework. The instruments range from short-dated 91-day, 182-day and 364-day Treasury Bills to longer dated securities, allowing the RBI to calibrate the maturity profile of liquidity absorption. The ceiling itself is dynamic: it has been revised mid-year on multiple occasions in response to shifting capital-flow conditions. The securities are tradeable in the secondary market and carry the same sovereign credit standing as ordinary government paper, which means they qualify for the Statutory Liquidity Ratio (SLR) and can be used in repo transactions, preserving their attractiveness to banks. When inflows reverse and liquidity tightens, the RBI can allow MSS securities to mature without rollover, automatically releasing the sequestered funds back into circulation, or it can buy them back—thereby unwinding sterilisation in a controlled manner.

Contemporary application of the scheme demonstrates its episodic, crisis-responsive character. The most dramatic recent invocation followed the demonetisation of high-value currency notes announced on 8 November 2016. The withdrawal of ₹500 and ₹1,000 notes triggered an enormous surge of deposits into the banking system, creating a liquidity glut that overwhelmed the RBI's conventional reverse-repo capacity. On 28 November 2016 the government, on the RBI's recommendation, raised the MSS ceiling to ₹6,00,000 crore to enable the central bank to issue cash management bills and absorb the excess. This deployment underscored that the scheme, though designed for forex-driven liquidity, is a flexible sterilisation tool adaptable to any source of durable surplus liquidity.

The MSS must be distinguished from adjacent liquidity instruments. Unlike Open Market Operations (OMOs), where the RBI buys or sells securities from its own portfolio and the cash impact flows through the central bank's balance sheet, the MSS relies on freshly issued government securities with proceeds impounded separately—it does not deplete the RBI's holdings. It differs from the Liquidity Adjustment Facility (LAF), comprising repo and reverse-repo operations, which manage transient, day-to-day liquidity at the policy rate; the MSS targets durable, structural surpluses. It is also conceptually separate from the Cash Reserve Ratio (CRR), a blunt, non-remunerated reserve requirement, whereas MSS securities are interest-bearing and market-traded. The defining feature remains the fiscal-monetary separation: the government borrows but cannot spend the proceeds.

Controversy has attended the scheme principally over its fiscal cost and accounting treatment. The interest burden on MSS securities falls on the exchequer even though the borrowing serves a monetary, not fiscal, purpose, prompting debate over whether the cost of sterilisation should be borne by the budget or the central bank. During the 2016 demonetisation episode, critics questioned the transparency of using MSS instruments at unprecedented scale and the resulting carrying costs. The scheme also raises questions of coordination between the Ministry of Finance and the RBI, since the ceiling and issuance require joint agreement, occasionally creating friction over the locus of monetary autonomy when sterilisation costs strain fiscal arithmetic.

For the working practitioner—whether a UPSC aspirant addressing GS Paper III, a banking-sector analyst, or a macroeconomic desk officer—the MSS exemplifies the institutional ingenuity required to reconcile exchange-rate management with monetary control under an open capital account. It illustrates the impossible trinity: India's attempt to manage the rupee while retaining monetary independence necessitates sterilisation, and the MSS is the bespoke instrument that operationalises that choice. Understanding the scheme equips the analyst to interpret RBI liquidity statements, gauge the fiscal cost of forex intervention, and anticipate how the central bank will respond to capital-flow surges or domestic liquidity shocks. Its dormant-then-deployed pattern makes it a recurring feature of India's monetary toolkit rather than a relic of 2004.